Viewing Study NCT02254434


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-02-27 @ 9:59 PM
Study NCT ID: NCT02254434
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2014-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cirrhosis, Liver View
Keywords:

Keywords

Keyword Brief Keyword Text View
None eltrombopag 50 mg View
None healthy volunteers View
None pharmacokinetic View
None single-dose View
None Open-label View
None fasting View